|
Usanova A.A., Novikova E.K., Kuzma F.M., Sergutova N.P.
COVID-19 and alcohol liver disease (literature review)
|
№3 / 2024
|
|
Mashin V.V., Belova L.A., Dudikov E.M., Slesareva E.V., Dolgova D.R., Nikishin K.E., Lyalchenko Yu.A.
Damage of nervous system in COVID-19: Neuropsychological syndromes, histological data
|
№5 / 2023
|
|
Bratilova E.S., Kachnov V.A., Tyrenko V.V., Afonaskov O.V.
Predictors of cardiovascular risk as prognostic factors of adverse course and outcomes of COVID-19 in young and middle age adults
|
№1 / 2023
|
|
Eremina E.Yu., Lityushkina M.I., Strokova O.A.
Features of pancreas damage in the patients with coronavirus infection
|
№7 / 2022
|
|
Kichigin V.A., Abyzov A.S., Chepurnaya O.P.
Features of kidney function in patients with a novel coronavirus infection COVID-19
|
№7 / 2022
|
|
Shishkova V.N.
Aspects of post-COVID asthenia symptoms correction
|
№5 / 2022
|
|
Malyavin A.G., Gorelov A.V., Antonova E.A., Pobedinskaya T.A., Globenko А.А., Kapashin A.V., Bagaeva M.I.
Efficacy and safety evaluation of Ingavirin® as COVID-19 antiviral therapy: clinical trial
|
№5 / 2022
|
|
Eremina E.Yu., Gerasimenko I.V., Lityushkina M.I., Strokova O.A.
Features of the course of pseudomembranous colitis in patients infected with SARS-CoV-2
|
№4 / 2022
|
|
Abyzov A.S., Tarasova L.V., Busalaeva E.I.
Hypoxic hepatitis as a manifestation of a new coronavirus infection
|
№2 (приложение) / 2022
|
|
Zakharov V.V., Gromova D.O.
Neurological manifestations of post-covid syndrome
|
№1 / 2022
|
|
Mazurov V.I., Belyaeva I.B., Sarantseva L.E., Chudinov A.L., Bashkinov R.A., Trofimov Е.А., Gaydukova I.Z., Smulskaya О.А., Inamova O.V., Petrova M.S., Khokhlova Y.V., Vasilenko Е.А., Melnikov Е.S.
Features of the clinical course of rheumatic diseases in patients who have had a new coronavirus infection
|
№10 / 2021
|
|
Zolotovskaya I.A., Gimatdinova G.R., Davydkin I.L., Sabanova V.D.
The phenotype of a patient with COVID-19: the tactics of making a decision on a timely hospitalization
|
№6 / 2021
|
Русский
